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9–13 years). Of the 106 participants, 18, 20, 44, and 24 individuals 
had 13 (general qualification of university entrance), 12 (subject-
related entrance qualification), 10 (intermediate school-leaving 
certificate), and 9 (secondary-school qualification) years of school 
education, respectively. The sample could be divided into 89 par-
ticipants (84%) with low and 15 (14%) with high occupational at-
tainment (2 participants could not be classified) [5]. The mean 
Expanded Disability Status Scale score was 3.46 ± 1.44 (range 0.5–
7.5). The mean disease duration (years since diagnosis) was 7.75 ± 
7.44 years (range 0–32 years). Eighteen participants were receiving 
antidepressants. Compared to published cut-off values, the sample 
demonstrated high fatigue scores (Fatigue Scale for Motor and 
Cognitive Functions, FSMC [6]; mean = 71.56 ± 16.35; range = 
35–100), whereas the depression value was within normal limits 
(mean = 21.17 ± 12.59; median = 19; range = 2–54). 
The study data showed no influence of gender, age, or disease 
duration on FoP. Furthermore, we found no variation in mean 
FoP-Q levels for different MS courses (relapsing-remitting MS, 
secondary-progressive MS, primary-progressive MS). This result 
suggests that FoP develops independently of the course that MS 
takes. Correlation analysis showed moderate to large associations 
of FoP-Q scales with depression (CES-D; 0.36 < r < 0.71) and with 
both action control subscales (Action Control Scale [7]; preoccu-
pation: 0.35 < r < 0.63, hesitation: 0.35 < r < 0.51). There were only 
small correlations between FoP-Q scales and the FSMC sum score 
and FSMC cognition score (0.27 < r < 0.31). 
Hierarchical regression analysis predicting depression re-
vealed a model in which 70% of the variance in the CES-D were 
explained by the following set of predictors (Table 1). The most 
valuable predictor was the FoP-Q subscale affective reaction. The 
items of this subscale describe anxiety about various domains of 
life, anxiety triggers, and forms of expression of anxiety. The pos-
itive β-coefficient indicates a frequent coexistence of anxiety and 
depressive reaction patterns. The next most relevant predictor was 
the FSMC sum score, which points to the close relationship of this 
predominant MS symptom to the symptoms of depression. The 
coping scale of the FoP-Q appears to be a valuable predictor of de-
pression as well. The inverse relationship suggests that the better 
the anxiety coping competencies, the lower the severity of depres-
sive mood states. Moreover, we found the Action Control Scale 
factor preoccupation to be a relevant variable. The negative 
β-coefficient indicates a reciprocal relationship: the larger this 
component of state-orientated behaviour, the lower the success in 
depressive mood regulation. Finally, the variables of education 
and occupational attainment were included in the regression 
model. Both seem to have an indirect protective effect on the lev-
el of depression. These findings accord with those of Pavlou and 
Counte’s [8] analysis of data on MS adjustment factors, such as 
attitudes, stereotypical beliefs, and disease knowledge. They found 
that a person‘s education level was a predictor of all 3 of these 
measures. 
Anxiety disorders are widespread among patients with chronic 
physical diseases, such as diabetes mellitus, cancer, and rheumatic 
diseases. Studies based on psychosocial stress screenings and dis-
ease-specific questionnaires have concluded that one specific anx-
iety is central to the patient’s life, i.e. the fear that the disease will 
progress, with all its consequences. Herschbach et al. [1] have 
called this the fear of progression (FoP). They defined FoP as a re-
active, non-neurotic emotional response that patients are fully 
aware of. The fear is based on the personal experience of a life-
threatening or incapacitating illness, and is experienced with emo-
tional, cognitive, behavioural, and physiological qualities [1]. 
Multiple sclerosis (MS) is also a progressive disease with an un-
predictable course. It is the most common cause of chronic neuro-
logical disability in young adults, with onset typically between the 
ages of 20 and 40 years [2]. According to our research, FoP seems 
to be underrecognized in people with MS. We aimed, therefore, to 
explore the relationship between FoP (Fear of Progression Ques-
tionnaire, FoP-Q [1]) and depression (Center for Epidemiologic 
Studies Depression Scale, CES-D [3, 4]), while controlling for de-
mographic, clinical, and psychological variables. 
The study sample (n = 106) showed typical demographic data 
for MS cohorts admitted to a neurological rehabilitation centre, 
with a predominance of females (76%) and a relapsing-remitting 
MS disease course (65%) (69 with relapsing-remitting MS, 13 with 
secondary-progressive MS, 21 with primary-progressive MS, 2 
with clinically isolated syndrome, and 1 with undetermined MS 
course). The mean age of the participants was 45.44 ± 9.16 years 
(range 25–65 years) (81 females: 45.23 ± 9.64, 25 males: 46.12 ± 
7.52). The duration of education was 10.67 ± 1.46 years (range 
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Overall, our results can be interpreted as an indication that FoP 
is a meaningful emotional stressor in patients with MS, especially 
in those with depression. It seems to be wise to distinguish FoP 
from psychiatric-based anxiety disorders, because individuals with 
MS are confronted with a real threat, and their reaction pattern 
should be considered as a functional response to an extraordinary, 
everlasting life event. This distinction should be considered in psy-
chotherapeutic treatments and, in our opinion, also applies to oth-
er MS-related anxiety disorders (e.g., fear of falling, fear of losing 
bladder control, fear of blindness). 
The strong relationship between FoP scales and depression cor-
responds to previous findings, which had observed that persons 
with MS express more variability in their emotional reactions to 
the disease than other chronic illness groups [9]. Brown et al. [10] 
suggested that the high comorbidity of anxiety and depression in 
MS studies might reflect a causal relationship between these symp-
toms, and that they are part of a broader psychosomatic disorder 
(a mixed anxiety-depression disorder). That would imply that ad-
justment to MS and its challenges needs to be conceptualized ther-
apeutically as a multidimensional psychological process.
Owing to the preliminary nature of our study, several short-
comings limit the generalizability of our findings, including the 
study’s cross-sectional design, the missing control group and the 
exclusive use of self-reported measures. Therefore, future research 
aimed at exploring the precise temporal and causal relationships 
of our symptom comorbidity should use a prospective longitudinal 
design. Moreover, in the future, we plan to examine the concept of 
FoP (in relation to depression) in patients with chronic diseases 
that do not affect the CNS. 
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Table 1. Hierarchical regression analysis (stepwise entering), predicting depression (CES-D)
CES-D Variable R change F change p value B SE B β p value
Step 1 Demographic variables (age, gender, education, occupational attainment), R2 = 0.17 (adj. R2 = 0.14) 
Occupational attainment 0.078 8.604 0.004 –7.969 3.419 –0.222 0.022
Education 0.042 4.856 0.030 –3.110 1.204 –0.248 0.011
Age 0.049 5.872 0.017 –0.316 0.130 –0.224 0.017
Step 2 Clinical variables (disease duration, EDSS, FSMC, antidepressive therapy), R2 = 0.45 (adj. R2 = 0.42), ∆R2 = 0.28
FSMC sum score 0.290 41.640 0.000 0.358 0.060 0.462 0.000
Education 0.061 9.450 0.003 –2.887 0.990 –0.231 0.004
Age 0.036 5.886 0.017 –0.345 0.111 –0.245 0.002
Antidepressive therapy 0.040 6.833 0.010 6.524 2.644 0.195 0.015
Occupational attainment 0.024 4.255 0.042 –5.837 2.829 –0.162 0.042
Step 3 Psychological variables (ACS), R2 = 0.63 (adj. R2 = 0.61), ∆R2  = 0.18
ACS preoccupation 0.446 82.116 0.000 –1.925 0.237 –0.535 0.000
FSMC sum score 0.102 22.744 0.000 0.248 0.051 0.320 0.000
Education 0.056 14.081 0.000 –0.2402 0.803 –0.192 0.003
Occupational attainment 0.023 6.169 0.015 –5.739 2.311 –0.160 0.015
Step 4 FoP-Q variables (affective reaction, family/partnership, occupation, loss of autonomy, coping), R2  = 0.72 (adj. R2 = 0.70), 
∆R2 = 0.9
FoP-Q affective reaction 0.497 100.959 0.000 0.369 0.091 0.309 0.000
FSMC sum score 0.108 27.543 0.000 0.209 0.046 0.270 0.000
FoP-Q anxiety coping 0.048 13.911 0.000 –0.488 0.151 –0.202 0.002
ACS preoccupation 0.024 7.293 0.008 –0.932 0.277 –0.259 0.001
Education 0.027 8.849 0.004 –1.757 0.735 –0.140 0.019
Occupational attainment 0.014 4.670 0.033 –4.419 2.045 –0.123 0.033
CES-D, Center for Epidemiologic Studies Depression Scale; EDSS, Expanded Disability Status Scale; FSMC, Fatigue Scale for Motor 
and Cognitive Functions (sum score); ACS, Action Control Scale; FoP-Q, Fear of Progression Questionnaire. B, Unstandardized 
Coefficient; SE B, standard error of B; β, standardized coefficient.
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